“…FKBP52 enhances, whereas FKBP51 attenuates PR-and GR-mediated transcription (25,26). Robust upregulation of FKBP51 levels by ligand-activated GR, and to a lesser extent by ligand-activated PR, is well established (28)(29)(30)(31). Our laboratory recently found (31) that 1) in cultured primary human decidual cells, FKBP51, but not FKBP52 levels, are up-regulated by either dexamethasone, a pure glucocorticoid, or medroxyprogesterone acetate, a mixed progestin-glucocorticoid (32,33), whereas Organon 2058, a pure progestin agonist exerted minimal stimulatory effects; 2) overexpression of FKBP5 resulted in inhibition of PR binding to progesterone response elements (PRE); and 3) at the maternal-fetal interface, FKBP51 is predominantly expressed in decidual cell nuclei with increased expression in term decidual cells among patients in labor compared with nonlaboring controls (31).…”